Accelerating early-stage drug discovery requires bridging the informatics gap between data analysis and molecular design, and Certara software achieves this seamlessly by integrating D360 with Chemaxon’s Design Hub. This powerful combination successfully completes the digitalization of the design-make-test-analyze cycle, empowering leading biopharmaceutical teams to focus entirely on core science. By providing self-service data access, advanced analytical tools, and streamlined hypothesis capture, the platform transforms raw information into actionable insights. Ultimately, Certara helps organizations shorten the timeline for data-driven decisions, formalize the transition between candidate rounds, and significantly enhance overall productivity in modern pharmaceutical research.

Join for free to read